Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$21.00
-0.52-2.39%
Last update: Oct 1, 2:59 PM
$21.04
-0.47-2.19%
Immunome Inc (IMNM) Stock Price, Quote, News & History
IMNMNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Immunome (NASDAQ:IMNM) through any online brokerage.
Other companies in Immunome’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Immunome has a consensus price target of $31.53.
The stock price for Immunome (NASDAQ: IMNM) is $20.995 last updated October 1, 2026 at 2:59 PM EDT.
There are no upcoming dividends for Immunome.
Immunome does not have any upcoming earnings scheduled.
There is no upcoming split for Immunome.
Immunome is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
